Kenneth J. Hillan

Insider Reports History

Entity
Individual
Location
C/O Achaogen, Inc., 7000 Shoreline Court, Suite 371, South San Francisco, California
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kenneth J. Hillan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
23andMe Holding Co. Chief Therapeutics Officer Class A Common Stock 222K $159K $0.72 Jun 5, 2023 Direct
SANGAMO THERAPEUTICS, INC Director Common Stock 74.6K $44.8K $0.60 Jun 4, 2024 Direct
SANGAMO THERAPEUTICS, INC Director Stock Option (Right to Buy) 50K Jun 4, 2024 Direct
Zymeworks Inc. Director Stock Option (Right to Buy) 37K Dec 7, 2023 Direct
Zymeworks Inc. Director Stock Option (Right to Buy) 9K May 6, 2021 Direct

Insider Reports Filed by Kenneth J. Hillan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SGMO SANGAMO THERAPEUTICS, INC Jun 4, 2024 2 $0 4 Jun 6, 2024 Director
ZYME Zymeworks Inc. Dec 7, 2023 1 $0 4 Dec 8, 2023 Director
ME 23andMe Holding Co. Jun 5, 2023 2 -$31.9K 4 Jun 7, 2023 Chief Therapeutics Officer
SGMO SANGAMO THERAPEUTICS, INC Jun 1, 2023 2 $0 4 Jun 5, 2023 Director
ME 23andMe Holding Co. May 20, 2023 1 -$8.98K 4 May 23, 2023 Chief Therapeutics Officer
ME 23andMe Holding Co. Feb 20, 2023 1 -$15.7K 4 Feb 22, 2023 Chief Therapeutics Officer
ZYME Zymeworks Inc. Dec 21, 2022 1 $0 4 Dec 23, 2022 Director
ME 23andMe Holding Co. Nov 20, 2022 1 -$13.8K 4 Nov 22, 2022 Chief Therapeutics Officer
ME 23andMe Holding Co. Aug 24, 2022 1 -$31.9K 4 Aug 25, 2022 Chief Therapeutics Officer
ME 23andMe Holding Co. Aug 20, 2022 1 -$15.4K 4 Aug 22, 2022 Chief Therapeutics Officer
ME 23andMe Holding Co. Jun 1, 2022 1 -$13K 4 Jun 2, 2022 Chief Therapeutics Officer
SGMO SANGAMO THERAPEUTICS, INC Feb 25, 2022 2 $0 4 Mar 1, 2022 Director
ME 23andMe Holding Co. Feb 9, 2022 2 $0 4 Feb 11, 2022 Head of Therapeutics
ME 23andMe Holding Co. Jun 16, 2021 0 $0 3 Jun 25, 2021 Head of Therapeutics
ZYME Zymeworks Inc. May 6, 2021 1 $0 4 May 7, 2021 Director